World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 May 2023
Main ID:  PACTR201412000962379
Date of registration: 06/12/2014
Prospective Registration: No
Primary sponsor: The Aga Khan University, Faculty of Health Sciences research committee
Public title: Remifentanil versus dexmedetomidine
Scientific title: A comparison of risk of hypotension using standard doses of remifentanil versus dexmedetomidine infusions, in adult patients undergoing elective surgery under general anaesthesia at the Aga Khan University Hospital, Nairobi.
Date of first enrolment: 01/05/2014
Target sample size: 100
Recruitment status: Recruiting
URL:  https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=962
Study type:  Interventional
Study design:  Factorial: participants randomly allocated to either no, one, some or all interventions simultaneously,Randomised,Simple randomisation using a radomisation table created by a computer software program,Sealed opaque envelopes  
Phase:  Not Applicable
Countries of recruitment
Kenya
Contacts
Name: vitalis    mung'ayi
Address:  3RD Parkalands Avenue, P.O. BOX 30270 00100 NAIROBI Kenya
Telephone: +254711092158
Email: mung'ayi.vitalis@aku.edu
Affiliation:  Content Supervisor of research study
Name: Ciiru    Kamanda
Address:  3RD Parkalands Avenue, P.O. BOX 30270 00100 NAIROBI Kenya
Telephone: +254203662107/2109
Email: kamanda.ciiru@aku.edu
Affiliation:  Research Unit Co-ordinator
Key inclusion & exclusion criteria
Inclusion criteria: ASA I or II patients
Patients aged 18-85 years
Elective surgical procedures

Exclusion criteria: BMI >35
Pregnant women
Patients with severe liver and renal dysfunction
Patients diagnosed to have mental disorders
Pre-existing bradycardia and brady-dysrhythmia
Cardiovascular insufficiency and valvular heart disease
Hypertensive patients


Age minimum: 18 Year(s)
Age maximum: 85 Year(s)
Gender: Both
Health Condition(s) or Problem(s) studied
Circulatory System

Circulatory System
Hypotension
Hypotension
Intervention(s)
Dexmedetomidine infusion
Remifentanil infusion
Primary Outcome(s)
hypotension
Secondary Outcome(s)
number of physician interventions
severity of hypotension
Secondary ID(s)
2014 rec-14
Source(s) of Monetary Support
The Aga Khan University, Faculty of Health Sciences research committee
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 22/08/2014
Contact:
The Aga Khan University, Nairobi Health Research Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history